Emmaus Life Sciences
(OTC) EMMA
Emmaus Life Sciences Financials at a Glance
Market Cap
$926,100
Revenue (TTM)
$11.89M
Net Income (TTM)
$7.29M
EPS (TTM)
$-0.11
P/E Ratio
-0.13
Dividend
$0.00
Beta (Volatility)
-0.61 (Low)
Dividend
$0.00
Beta (Volatility)
-0.61 (Low)
Price
$0.01
Volume
405
Open
$0.01
Price
$0.01
Volume
405
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.03
Dividend
$0.00
Beta (Volatility)
-0.61 (Low)
Price
$0.01
Volume
405
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.03
EMMA News
EMMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Emmaus Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
35
CEO
Willis C. Lee
Website
www.emmausmedical.comHeadquarters
Torrance, CA 90503, US
EMMA Financials
Key Financial Metrics (TTM)
Gross Margin
92%
Operating Margin
-10%
Net Income Margin
-61%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-35%
Earnings Yield
-7.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$926.10K
Shares Outstanding
63.87M
Volume
405
Short Interest
0.00%
Avg. Volume
24.93K
Financials (TTM)
Gross Profit
$15.45M
Operating Income
$1.89M
EBITDA
$910.00K
Operating Cash Flow
$2.29M
Capital Expenditure
$12.00K
Free Cash Flow
$2.30M
Cash & ST Invst.
$1.39M
Total Debt
$32.96M
Emmaus Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.38M
-38.3%
Gross Profit
$3.13M
-38.4%
Gross Margin
92.69%
N/A
Market Cap
$926.10K
N/A
Market Cap/Employee
$27.24K
N/A
Employees
34
N/A
Net Income
$2.08M
-213.6%
EBITDA
$449.00K
-85.8%
Quarterly Fundamentals
Net Cash
$31.39M
+1.3%
Accounts Receivable
$2.62M
-47.5%
Inventory
$1.21M
-24.7%
Long Term Debt
$3.76M
+13.4%
Short Term Debt
$27.92M
-6.1%
Return on Assets
-35.12%
N/A
Return on Invested Capital
2.79%
N/A
Free Cash Flow
$409.00K
+174.5%
Operating Cash Flow
$409.00K
+176.4%